ticagrelor

Generic: ticagrelor

Labeler: novadoz pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ticagrelor
Generic Name ticagrelor
Labeler novadoz pharmaceuticals llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ticagrelor 90 mg/1

Manufacturer
Novadoz Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 72205-368
Product ID 72205-368_fb424a50-a319-4227-851f-2f59d236adf2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208596
Listing Expiration 2027-12-31
Marketing Start 2020-04-07

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72205368
Hyphenated Format 72205-368

Supplemental Identifiers

RxCUI
1116635 1666332
UPC
0372205368187 0372205368910 0372205368996 0372205406018 0372205368606 0372205368064 0372205406025
UNII
GLH0314RVC
NUI
N0000182142 N0000008832 N0000182143 N0000182141 N0000185503

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ticagrelor (source: ndc)
Generic Name ticagrelor (source: ndc)
Application Number ANDA208596 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 90 mg/1
source: ndc
Packaging
  • 10 BLISTER PACK in 1 BOX, UNIT-DOSE (72205-368-11) / 10 TABLET in 1 BLISTER PACK
  • 180 TABLET in 1 BOTTLE (72205-368-18)
  • 60 TABLET in 1 BOTTLE (72205-368-60)
  • 100 TABLET in 1 BOTTLE (72205-368-91)
  • 1000 TABLET in 1 BOTTLE (72205-368-99)
source: ndc

Packages (5)

72205-368-11 10 BLISTER PACK in 1 BOX, UNIT-DOSE (72205-368-11) / 10 TABLET in 1 BLISTER PACK 72205-368-18 180 TABLET in 1 BOTTLE (72205-368-18) 72205-368-60 60 TABLET in 1 BOTTLE (72205-368-60) 72205-368-91 100 TABLET in 1 BOTTLE (72205-368-91) 72205-368-99 1000 TABLET in 1 BOTTLE (72205-368-99)

Ingredients (1)

ticagrelor (90 mg/1)

Linked Drug Pages (1)

TICAGRELOR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fb424a50-a319-4227-851f-2f59d236adf2", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0372205368187", "0372205368910", "0372205368996", "0372205406018", "0372205368606", "0372205368064", "0372205406025"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["b1c29d47-960f-4fc4-b6ff-399e2c6eec4c"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 BOX, UNIT-DOSE (72205-368-11)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "72205-368-11", "marketing_start_date": "20250501"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (72205-368-18)", "package_ndc": "72205-368-18", "marketing_start_date": "20250501"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (72205-368-60)", "package_ndc": "72205-368-60", "marketing_start_date": "20250501"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (72205-368-91)", "package_ndc": "72205-368-91", "marketing_start_date": "20250501"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (72205-368-99)", "package_ndc": "72205-368-99", "marketing_start_date": "20250501"}], "brand_name": "TICAGRELOR", "product_id": "72205-368_fb424a50-a319-4227-851f-2f59d236adf2", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "72205-368", "generic_name": "TICAGRELOR", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TICAGRELOR", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "ANDA208596", "marketing_category": "ANDA", "marketing_start_date": "20200407", "listing_expiration_date": "20271231"}